Partners

Partners

Supporting Associations

The Chinese American Biopharmaceutical Society (CABS) is a non-profit organization for professionals in the biopharmaceutical industry. CABS is headquartered in San Francisco Bay Area, California. About 70% of our members have PhD degree relating to life sciences. A considerable proportion of the members are holding senior research and management positions in American and multi-national life sciences corporations. Many of our members are experts and leaders, innovative entrepreneurs, lawyers and venture capitalists or investors in the life sciences sector. CABS is the largest and most active Chinese biopharmaceutical association in Northern America.

IBC

The Chinese Biopharmaceutical Association (CBA-USA) is one of the largest Chinese American professional associations in the US (www.cba-usa.org). Founded in 1995, CBA is an independent, non-political, not-for-profit professional organization led by its elected board of directors, board of advisors and executive committees.

CBA’s primary mission is to bridge biopharmaceutics between US and China. Headquartered in Maryland, CBA currently has more than 3000 registered individual members, and more than 60 institutional members. Most of the CBA members are from the local biopharmaceutical companies, universities, research institutions, and government agencies. More than 80 percent of the CBA members have doctoral degrees. In addition to members from the US, CBA also has members residing in China, Europe, Canada, Australia, Singapore, and Japan.

Media Partners

Asia Pacific Biotech News (APBN) magazine is one of the publication of World Scientific Publishing Co. (WSPC). It is a monthly print and online premium magazine focused on biotechnology, healthcare and pharmaceutical news happening in China and in other Asia Pacific countries. It is widely read by doctors and professors, industry professionals/experts, biotech investors, researchers, scientists, university students, etc.

APAC CIOoutlook is a print magazine that aims to provide a platform for CIOs, CTOs and other senior level IT buyers and decision makers along with CXOs of solution providers to share their experiences, wisdom and advice with enterprise IT community of APAC countries. We promote our unique ‘learn from our peers approach’ in the Asia Pacific region.

From enterprise applications to the leading trends in big data, mobile computing, security and the Cloud, APAC CIOoutlook delivers practical, actionable information from senior practitioners in the trenches. We leverage our extensive peer-to-peer network, among leading technology executives, to bring their experience and the best practices to other members of CIO community in Asia Pacific countries.

We also identify and profile emerging companies providing cutting edge solutions to enterprises in APAC. For every technology and every industry vertical, our research team has access to and has deep background research done on hundreds of vendors providing solutions in APAC. Published from the hub of technology, Silicon Valley, USA with sales office in Hong Kong and editorial presence in all major APAC countries. APAC CIOoutlook is designed to connect the Enterprise IT community of APAC countries.

Bentham Science Publishers is rendering a vital service in the quality publication that publishes over 100 peer-reviewed print and online scientific, technical and medical journals. These titles are indexed in recognized indexing agencies, such as Science Citation Index®, Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, EMBASE etc. Some of the high impact titles which enjoy a wide reach and distribution are Current Gene Therapy (Impact Factor 4.906), Current Alzheimer Research (Impact Factor 3.796), Current Medicinal Chemistry (Impact Factor 3.715), and other popular titles.

Bentham has an extensive library of eBooks in the areas of science, technology, medicine, social sciences and humanities. Bentham eBooks publishes monographs, handbooks, conference proceedings, textbooks, review volumes, biographies and autobiographies.

 

BioPharma Asia aims to keep its readers abreast of all developments in the areas of Drug Development, Drug Delivery, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles, written by the most respected authors, associated with only end-user companies. This ensures that the information will always be guaranteed to remain timely, informative and above all totally unbiased.

 

 

The world is interconnected and complex. Understanding and simplifying it is difficult. At BMI Research, that challenge is what inspires us. Through ‘Total Analysis,’ our unique, reflexive approach linking macroeconomic, industry and financial market analysis, BMI Research helps clients gain unparalleled insight across 24 industries and 200 global markets. For more than 30 years, our forecasts, data and analyses have been used by multinationals, governments and financial institutions to guide critical strategic, tactical and investment decisions. Clients include a majority of Global Fortune 500 companies. With offices in London, New York, Singapore, Hong Kong, Dubai and South Africa, BMI Research is part of Fitch Group, which is majority owned by Hearst.

Genetic Engineering and Biotechnology News (GEN) is the longest-running, most widely read, and largest circulated global biotechnology news publication. Published 21 times a year and recently redesigned to focus on Biobusiness, OMICS, Drug Discovery, Bioprocessing, and Translational Medicine, GEN reports on key news developments and technology trends in the bioindustry.

Lingmed Ltd was founded in 2013 in Hong Kong, currently we have offices in Shanghai and Beijing. Lingmed promotes three leading intelligence databases for healthcare professionals in China to make better decisions. Lingmed's core products are healthcare intelligence databases; it covers global innovative assets & China market intelligence. Lingmed's Products and Services have been recognized by Fortune 500 multinational pharma and device companies as well as Chinese local big pharmacos. In addition, we together with our partners in Europe provide partnering services to bridge European and Chinese pharmaceuticals with biotech companies, including valuation and market monitoring reports.

灵麦公司是全球三家权威的数据开发公司在中国的独家代理。灵麦的核心产品是医药情报数据库,向大中型医药企业推广医药数据库,其服务和产品以被大多全球500强的大型外资药企和中国本土大型药企认可。此外我们与我们欧洲的合作伙伴携手为欧洲和中国的制药公司提供产品引进,公司收购的服务等。

Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.

Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world.
Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.

KONGPOSH Publications is one of the leading Pharma publishers of India. Our publications are - The Pharma Review® is a bi-monthly article based journal. Covering news, views and articles on various fields of pharmacy including Clinical Trials, Biotechnology, Review/Research papers, Herbal Medicine and much more. Contributions received from Eminent pharma personalities from India as well as other countries which helps us to have a varied and rich content matter. Participation and distribution in over 20 Expos & Conferences worldwide each year. It is widely read by decision makers, middle management and the academia. The journal is Abstracted & Indexed in International Pharmaceutical Abstract & Chemical Abstract – USA, Index Copernicus – Poland & Ulrich's Journal Database - USA for the quality of its content. Also available on our website and E-book format.

For regular complimentary link of the journal write to us on kongposhpub@gmail.com.

In the realm of Pharmacy, where innovation is rapid, Pharmaceutical-Tech stands adept at conceptualizing unique ideas relevant to the B2B space. Pharmaceutical-Tech is essentially a B2B online business, technology media platform and global magazine that have under its wraps the largest global database of Pharmacy buyers and suppliers. Pharmaceutical-Tech.com covers in-depth trends that shape industry dynamics and metamorphose global economics. With services like search engine optimization, global magazine, social media marketing, product video showcase, e-mail marketing, e-newsletter sponsorship, banner advertising, event marketing and micro-website within our platform, www.pharmaceutical-tech.com has created a recognition that spans over a global audience, thereby revolutionizing how businesses transact.

Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical / biopharmaceutical industry and market.

Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most multinational pharmaceutical companies, leading CROs, investment banks and consulting firms active in China as well as relevant industry associations and government agencies.

Pharma ChinaJournal Edition (monthly in PDF and Print)
Pharma China Web Edition (continuously-updated news, in-depth commentaries and online databases) 
China Pharmaceutical Guide (the most comprehensive and authoritative reference for China’s healthcare sector)

 

Informa’s Pharma Intelligence is the trusted partner of all of the top 50 global pharmaceutical companies and the top 10 contract research organisations (CRO’s) – providing timely intelligence and insight to help them make authoritative decisions.

From drug and device discovery and development to regulatory approval, drug reimbursement to lifecycle management – we provide the global intelligence and insight to help advance our partners’ initiatives in a fast changing market.

Pharma Intelligence是Informa集团旗下商业信息业务中的医药信息品牌,专注于为制药公司、医疗器械公司、CROs、学术研究机构、政府机构及咨询公司提供在临床研发、监管审批、市场竞争、业务发展与项目许可等方面的权威信息、报告及咨询服务。

Technology Networks has been established for over 10 years and is now the leading provider of free information services for life science professionals. This includes news, events, posters, videos, webcasts, application notes, new products, a literature search engine and product directories. The information is specifically tailored to over 30 individual communities with specific interests, all of which can be accessed through TechnologyNetworks.com.

International Marketing Partner

Global Information, Inc. (GII) is an information service company holding offices in 6 countries and have sales agency contracts with over 250 research companies around the world. We sell 30,000 market research reports published by these publishers and accept custom-made researches. With offices in Japan, Korea, Singapore, Taiwan, Brussels, and the United States, we have expanded our client base and provide continuous 24 hour service around the globe. GII's experience and proactive marketing philosophy have allowed us to develop key relationships with suppliers and customers, and provide our clients with the highest quality business intelligence available. Visit us at http://www.the-infoshop.com/ for more information.

Partnership

Media & Association Partnership Opportunities

If you are interested in exploring avenues for supporting this conference as a Media or Association Partner, please contact:

June Tan

+65 6508 2465

June.Tan@ibcasia.com.sg